RHEB loss suppressed de novo nucleotide biosynthesis, leading to human T-ALL promoted cell death in vitro and in vivo, both in mouse and xenograft models (Pham et al., 2022). This evidence concerns the gene RHEB and acute lymphoblastic leukemia.